Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Insight Molecular Diagnostics, Inc (United States)
Homepage:
imdxinc.com
Alternate names:
Insight Molecular Diagnostics,
Insight Molecular Diagnostics, Inc,
Oncocyte,
Oncocyte Corporation
ROR:
045weg456
OpenAlex ID:
I4405281304
Spatial predictors of immunotherapy response in triple-negative breast cancer
2023
·
Xiao Qian Wang
, Esther Danenberg
, et al.
·
Nature
·
394
PDF
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical Signatures
2018
·
Joo Sang Lee
, Lital Adler
, et al.
·
Cell
·
308
Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
2013
·
Jim Sang
, Jaime Acquaviva
, et al.
·
Cancer Discovery
·
211
Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients
2016
·
Brian Z. Ring
, David R. Hout
, et al.
·
BMC Cancer
·
79
PDF
Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
2018
·
Kenichi Harano
, Ying Wang
, et al.
·
PLoS ONE
·
49
PDF
Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue
2017
·
Bojana Jovanović
, Quanhu Sheng
, et al.
·
BMC Cancer
·
49
PDF
A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer
2021
·
Toshiaki Iwase
, Kim R. M. Blenman
, et al.
·
Cancers
·
47
PDF
Improving Cancer Care Delivery: Learnings for Oncology Nurses and Patient Navigation From a National Quality Survey
2022
·
Jennifer Aversano, MSN, RN, OCN, BMTCN
, Leigh M. Boehmer, PharmD, BCOP
, et al.
·
Journal of the Advanced Practitioner in Oncology
·
44
PDF
Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy
2022
·
Hiroko Masuda
, Kenichi Harano
, et al.
·
JCO Precision Oncology
·
42
PDF
Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research
2020
·
Jose Rodrigo Espinosa Fernandez
, Bedrich L. Eckhardt
, et al.
·
PLoS ONE
·
38
WIN site inhibition disrupts a subset of WDR5 function
2022
·
Andrew J. Siladi
, Jing Wang
, et al.
·
Scientific Reports
·
35
PDF
A novel immuno-oncology algorithm measuring tumor microenvironment to predict response to immunotherapies
2021
·
Tyler J. Nielsen
, Brian Z. Ring
, et al.
·
Heliyon
·
33
PDF
The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer
2024
·
Matteo Dugo
, Chiun-Sheng Huang
, et al.
·
Clinical Cancer Research
·
31
PDF
Performance of a RT-PCR Assay in Comparison to FISH and Immunohistochemistry for the Detection of ALK in Non-Small Cell Lung Cancer
2017
·
David Hout
, Brock Schweitzer
, et al.
·
Cancers
·
28
PDF
Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype
2019
·
Yohei Funakoshi
, Ying Wang
, et al.
·
PLoS ONE
·
23
PDF
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
2023
·
Carlotta Antoniotti
, Alessandra Boccaccino
, et al.
·
Clinical Cancer Research
·
20
Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer
2022
·
Harsha Ranganath
, Amit L. Jain
, et al.
·
BMC Cancer
·
17
PDF
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer
2023
·
David B. Page
, Joanna Pucilowska
, et al.
·
npj Breast Cancer
·
13
PDF
Detection of a TRAF1-ALK fusion in an anaplastic large cell lymphoma patient with chemotherapy and ALK inhibitor-resistant disease
2015
·
Kasey Lawrence
, Brian Berry
, et al.
·
BMC Research Notes
·
10
PDF
Personalized medicine for pathological circadian dysfunctions
2015
·
Rachel L. Skelton
, Jon M. Kornhauser
, et al.
·
Frontiers in Pharmacology
·
10
PDF
Longitudinal transcriptomic profiling identifies predictors of response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer: results from the NeoTRIPaPDL1 trial
2026
·
M. Dugo
, C.-S. Huang
, et al.
·
Annals of Oncology
·
8
Successful treatment of hepatic oligometastases with stereotactic ablative radiotherapy and radiofrequency ablation in an anaplastic lymphoma kinase fusion‐positive lung cancer patient
2015
·
Britta Weber
, Mitchell Liu
, et al.
·
Journal of Medical Radiation Sciences
·
8
PDF
Bcl10 is an essential regulator for A20 gene expression
2013
·
Wu Xu
, Liquan Xue
, et al.
·
Journal of Physiology and Biochemistry
·
8
Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT)
2025
·
Gliceida M. Galarza Fortuna
, Daniel Grass
, et al.
·
Journal for ImmunoTherapy of Cancer
·
7
PDF
Abstract P2-07-12: Triple negative breast cancer subtypes and early dynamics of the 27-gene IO score predict pCR in the NeoTRIPaPDL1 trial
2022
·
Matteo Dugo
, Chiun-Sheng Huang
, et al.
·
Cancer Research
·
7
Show more works
View as search
Works count:
63
Works count with child and predecessor institutions:
95
Citation count:
1,649
Year
Topic
Type
